Acute Phase Proteins as Early Markers in Sepsis

This study is not yet open for participant recruitment.

Verified by University of Zurich, March 2008

First Received: March 17, 2008 Last Updated: March 21, 2008 History of Changes

Sponsored by:	University of Zurich
Information provided by:	University of Zurich
ClinicalTrials.gov Identifier:	NCT00641355

Purpose

Monitoring of different serumproteins after severe trauma and during trauma-induced sepsis.

Condition	Intervention
Sepsis	Procedure: No intervention

MedlinePlus related topics: Sepsis

Study Type:	Observational
Study Design:	Case-Only, Prospective
Official Title:	Acute Phase Proteins as Early Markers in Sepsis

Further study details as provided by University of Zurich:

Biospecimen Retention: None Retained

Biospecimen Description:

Estimated Enrollment:	15
Study Start Date:	April 2008
Estimated Study Completion Date:	September 2012

Intervention Details:

No intervention

Eligibility

Study Population

Patients with severe trauma

Criteria

Inclusion criteria:

Exclusion criteria:

Moribund patients (pH <7,1, lactate >15mmol, Basedeficit > 15mEq/L, severe heart or liver injuries, GCS never over 5 after trauma)
Severe head injuries (AIS head >4)
Patient with severe infectious diseases, or diseases which severely affect the immune system (diabetes, Alkohol or nicotine abuse)
Non-german speaking patients

Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00641355

Contacts

Contact: 01 Studienregister MasterAdmins

+41 (0)44 255 11 11

Locations

Sponsors and Collaborators

University of Zurich

Investigators

Study Director:

01 Studienregister MasterAdmins

UniversitaetsSpital Zuerich

More Information

No publications provided

Responsible Party:	University Hospital of Zurich ( PD Dr. Marius Keel )
Study ID Numbers:	StV 26-2007
Study First Received:	March 17, 2008
Last Updated:	March 21, 2008
ClinicalTrials.gov Identifier:	NCT00641355 History of Changes
Health Authority:	Switzerland: Swissmedic

Study placed in the following topic categories:

Systemic Inflammatory Response Syndrome
Sepsis
Inflammation

Additional relevant MeSH terms:

Systemic Inflammatory Response Syndrome
Sepsis
Pathologic Processes
Infection
Inflammation

ClinicalTrials.gov processed this record on May 06, 2009